136 related articles for article (PubMed ID: 28624049)
1. Failure to operate on resectable gastric cancer: implications for policy changes and regionalization.
Frohman HA; Martin JT; Le AT; Dineen SP; Tzeng CD
J Surg Res; 2017 Jun; 214():229-239. PubMed ID: 28624049
[TBL] [Abstract][Full Text] [Related]
2. Predictors of Survival in Patients with Resectable Gastric Cancer Treated with Preoperative Chemoradiation Therapy and Gastrectomy.
Badgwell B; Blum M; Estrella J; Chiang YJ; Das P; Matamoros A; Fournier K; Mansfield P; Ajani J
J Am Coll Surg; 2015 Jul; 221(1):83-90. PubMed ID: 26002780
[TBL] [Abstract][Full Text] [Related]
3. Postoperative complications do not impact on recurrence and survival after curative resection of gastric cancer.
Climent M; Hidalgo N; Vidal Ó; Puig S; Iglesias M; Cuatrecasas M; Ramón JM; García-Albéniz X; Grande L; Pera M
Eur J Surg Oncol; 2016 Jan; 42(1):132-9. PubMed ID: 26385054
[TBL] [Abstract][Full Text] [Related]
4. Hospital variation and the impact of postoperative complications on the use of perioperative chemo(radio)therapy in resectable gastric cancer. Results from the Dutch Upper GI Cancer Audit.
Schouwenburg MG; Busweiler LAD; Beck N; Henneman D; Amodio S; van Berge Henegouwen MI; Cats A; van Hillegersberg R; van Sandick JW; Wijnhoven BPL; Wouters MWJ; Nieuwenhuijzen GAP;
Eur J Surg Oncol; 2018 Apr; 44(4):532-538. PubMed ID: 29439836
[TBL] [Abstract][Full Text] [Related]
5. Long term follow up and retrospective study on 533 gastric cancer cases.
Zeng WJ; Hu WQ; Wang LW; Yan SG; Li JD; Zhao HL; Peng CW; Yang GF; Li Y
BMC Surg; 2014 May; 14():29. PubMed ID: 24886548
[TBL] [Abstract][Full Text] [Related]
6. Adherence with operative standards in the treatment of gastric cancer in the United States.
Zhao B; Blair SL; Katz MHG; Lowy AM; Kelly KJ
Gastric Cancer; 2020 May; 23(3):550-560. PubMed ID: 31745679
[TBL] [Abstract][Full Text] [Related]
7. Trends in the use and impact of neoadjuvant chemotherapy on perioperative outcomes for resected gastric cancer: Evidence from the American College of Surgeons National Cancer Database.
Greenleaf EK; Hollenbeak CS; Wong J
Surgery; 2016 Apr; 159(4):1099-112. PubMed ID: 26704785
[TBL] [Abstract][Full Text] [Related]
8. Survival outcomes of geriatric patients with clinically resectable gastric cancer: to operate or not.
Liu KH; Hung CY; Lu CH; Hsu JT; Yeh TS; Lin YC; Hung YS; Chou WC
J Surg Res; 2016 Dec; 206(2):481-489. PubMed ID: 27884346
[TBL] [Abstract][Full Text] [Related]
9. Pretreatment Neutrophil to Lymphocyte Ratio Independently Predicts Disease-specific Survival in Resectable Gastroesophageal Junction and Gastric Adenocarcinoma.
Wang SC; Chou JF; Strong VE; Brennan MF; Capanu M; Coit DG
Ann Surg; 2016 Feb; 263(2):292-7. PubMed ID: 25915915
[TBL] [Abstract][Full Text] [Related]
10. [Hospital volume effects in surgical treatment of gastric cancer : Results of a prospective multicenter observational study].
Ptok H; Gastinger I; Meyer F; Ilsemann A; Lippert H; Bruns C
Chirurg; 2017 Apr; 88(4):328-338. PubMed ID: 27678401
[TBL] [Abstract][Full Text] [Related]
11. Geographic disparities in surgical treatment recommendation patterns and survival for pancreatic adenocarcinoma.
Salami A; Alvarez NH; Joshi ART
HPB (Oxford); 2017 Nov; 19(11):1008-1015. PubMed ID: 28838634
[TBL] [Abstract][Full Text] [Related]
12. Urgent Surgery for Gastric Adenocarcinoma: A Study of the National Cancer Database.
Fisher BW; Fluck M; Young K; Shabahang M; Blansfield J; Arora TK
J Surg Res; 2020 Jan; 245():619-628. PubMed ID: 31522035
[TBL] [Abstract][Full Text] [Related]
13. Opportunities to Improve Care of Hepatocellular Carcinoma in Vulnerable Patient Populations.
Hoehn RS; Hanseman DJ; Dhar VK; Go DE; Edwards MJ; Shah SA
J Am Coll Surg; 2017 Apr; 224(4):697-704. PubMed ID: 28069526
[TBL] [Abstract][Full Text] [Related]
14. Geographical differences in cancer treatment and survival for patients with oesophageal and gastro-oesophageal junctional cancers.
Jestin Hannan C; Linder G; Kung CH; Johansson J; Lindblad M; Hedberg J
Br J Surg; 2020 Oct; 107(11):1500-1509. PubMed ID: 32484241
[TBL] [Abstract][Full Text] [Related]
15. Trends in the use of evidence-based therapy for resectable gastric cancer.
Snyder RA; Penson DF; Ni S; Koyama T; Merchant NB
J Surg Oncol; 2014 Sep; 110(3):285-90. PubMed ID: 24891231
[TBL] [Abstract][Full Text] [Related]
16. Impact of hospital volume on recurrence and survival after surgery for gastric cancer.
Enzinger PC; Benedetti JK; Meyerhardt JA; McCoy S; Hundahl SA; Macdonald JS; Fuchs CS
Ann Surg; 2007 Mar; 245(3):426-34. PubMed ID: 17435550
[TBL] [Abstract][Full Text] [Related]
17. Adoption of evidence-based novel therapies in the treatment of gastric cancer: A national observational study.
Mokdad AA; Ali A; Yopp AC; Polanco PM; Nassour I; Mansour JC; Choti MA; Minter RM; Wang SC; Porembka MR
Cancer; 2018 Mar; 124(6):1122-1131. PubMed ID: 29211302
[TBL] [Abstract][Full Text] [Related]
18. Association of Preoperative Chemosensitivity With Postoperative Survival in Patients With Resected Gastric Adenocarcinoma.
Deng L; Groman A; Jiang C; Perimbeti S; Gabriel E; Kukar M; Mukherjee S
JAMA Netw Open; 2021 Nov; 4(11):e2135340. PubMed ID: 34797369
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors and outcomes in Italian patients undergoing curative gastric cancer surgery.
Posteraro B; Persiani R; Dall'Armi V; Biondi A; Arzani D; Sicoli F; Bonassi S; D'Ugo D; Ricciardi W; Boccia S
Eur J Surg Oncol; 2014 Mar; 40(3):345-51. PubMed ID: 24268760
[TBL] [Abstract][Full Text] [Related]
20. Association of socioeconomics, surgical therapy, and survival of early stage hepatocellular carcinoma.
Peters NA; Javed AA; He J; Wolfgang CL; Weiss MJ
J Surg Res; 2017 Apr; 210():253-260. PubMed ID: 28457336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
